PSA and APSA Re-affirm Partnership to Bridge Evidence to Practice Gap

Pharmaceutical Society of Australia (PSA)

Pharmaceutical Society of Australia (PSA) and The Australasian Pharmaceutical Science Association (APSA) are delighted to refresh their partnership for 2022-2023.

The Memorandum of Understanding (MOU) reaffirms both PSA and APSA’s commitment to ensuring the opportunity for research in pharmacy practice and pharmaceutical sciences is more recognised amongst the pharmacy community and for research to be translated and implemented into the practice of pharmacy and health service delivery.

PSA in partnership with APSA, will be hosting the research stream at the PSA22 conference, to enrich the level of research presented as the foundation for evidence-based pharmacist’s roles into 2023.

“PSA remains committed to maintaining a strong research culture across the profession, to ensure a robust evidence base for existing and future pharmacist programs. PSA looks forward to continuing to work with APSA to advance research in pharmacist-delivered care, and pharmaceutical sciences.” PSA National President A/Prof Chris Freeman said.

“We have received an exciting range of research papers ahead of our conference, including on medicine safety, models of care, innovation and scholarship in education, pandemic priorities and more.”

APSA President A/Prof Joseph Nicolazzo also welcomed the MOU.

“APSA is very excited to continue this collaborative relationship with PSA. This joint effort not only facilitates effective showcasing of pharmacy practice and pharmaceutical science research outcomes to PSA members but allows for APSA and PSA members to work symbiotically through PSA-sponsored workshops and a plenary lecture at the APSA Annual Conference.”

PSA22 will be held from 29-31 July 2022 at the Hyatt Regency in Sydney. You can find

/Public Release.